Show simple item record

dc.contributor.authorAnnan, William Gilliesen
dc.date.accessioned2018-01-31T11:15:47Z
dc.date.available2018-01-31T11:15:47Z
dc.date.issued1938
dc.identifier.urihttp://hdl.handle.net/1842/26127
dc.description.abstracten
dc.description.abstractThe short paragraphs, headed "Comments ", have been added, following the description of each group of cases, in order to avoid making this section of the Thesis too cumbersome to read, but I would like to stress certain points:-en
dc.description.abstract(1) By administering Sulphanilamide in small daily doses (2 gm and'under) the tendency to relapse, and to subsequent resistance to therapy, is definitely increased.en
dc.description.abstract(2) Relapses were most commonly occurred in the nervous, introspective type of patient, and since withholding Sulphanilamide from this type in such cases, and not giving small doses, I have not encountered any further relapses.en
dc.description.abstract(3) Patients who do not respond to Sulphanilamide therapy within 10 days need not be expected to do so at all.en
dc.description.abstract(4) Complications of the disease, especially prostatitis, do not respond favourably to Sulphanilamide treatment.en
dc.description.abstract(5) Routine urethroscopy, and repeated prostatic smear tests should be carried out in all cases preparatory to discharging them, in view of the possibility of "Latent Littritis ", and "Prostatitis ".en
dc.description.abstract(6) It should be very strongly impressed upon each patient, the necessity for regular and continued attendance until they are discharged. This is of special importance in view of the early favourable reaction to Sulphanilamide treatment which occurs in the great majority of cases.en
dc.description.abstract(7) Large doses of Sulphanilamide are not necessary, or advisable, particularly in patients who are debilitated.en
dc.description.abstract(8) In my experience a dose of 4 gm daily of Sulphanilamide has provided the best results.en
dc.description.abstractResults to date are incomplete in that the amount of material examined, and the conclusions fairly drawn therefrom are insufficient to allow one to propound a scheme of treatment applicable to, and curative of, every case.en
dc.description.abstractI would therefore recommend that further observations towards the possibility of application, of the various Sulphanilamide group drugs in different stages of gonococcal infection, as follows:-en
dc.description.abstract(a) '693' in Immediate or Delayed Cases. (b) Sulphanilamide or Uleron in Delayed Cases. (c) All three drugs, individually of course, without irrigation therapy. (d) Despite my disappointing results with Vaccine treatment, the effect of early vaccine i;muno- response in the Delayed group of cases.en
dc.publisherThe University of Edinburghen
dc.relation.ispartofAnnexe Thesis Digitisation Project 2017 Block 15en
dc.relation.isreferencedbyen
dc.titleSulphanilamide group of drugs in the treatment of gonococcal infectionen
dc.typeThesis or Dissertationen
dc.type.qualificationlevelDoctoralen
dc.type.qualificationnameMD Doctor of Medicineen


Files in this item

This item appears in the following Collection(s)

Show simple item record